The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
12 December 2016 Ottawa, Ontario On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. Download Summary Report Real-world evidence: What role can it play in real-world decision making? Summary Report The…
7 November 2016Edmonton, Alberta Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 16th IHE Innovation Forum Keynote Speakers were Dr. Richard B. Saltman, Co-founder of the European Observatory on Health Systems…
6 October 2016 Edmonton, Alberta This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists to describe the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.…
22 June 2016Edmonton, Alberta High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 15th IHE Innovation Forum Keynote Speakers were Dr. Clemens Hong, Medical…
| Anderson Chuck, Thanh Nguyen, James Wesenberg, Rhada Chari, Robert Wilson, Selikke Janes-Kelley
Objectives: In 2006, the Alberta Ministry of Health issued a policy to implement fetal fibronectin (fFN) testing as a publicly funded service for pregnant women. The goals were to reduce maternity health care utilization and unnecessary treatment, which would result in cost-savings for the health system by more accurately diagnosing false preterm labour. We conducted a post-policy…
25 April 2016 Toronto, Ontario On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care. The forum…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…
8 February 2016 Edmonton, Alberta The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum aimed to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which was attended by Health Minister Sarah Hoffman…
2018 | 2017 |2016 | 2015 | 2014 | 2013 The Institute of Health Economics joined with Alberta Innovates (formerly known as Alberta Innovates-Health Solutions) in 2013 to create a new forum to bring stakeholders together to discuss health policy. The AI/IHE Health Policy Speaker Series features perspectives from leaders in the health system across the spectrum of health evidence,…
25 – 26 November 2010 Edmonton, Alberta On 25 – 26 November 2010 in Edmonton a national forum: Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue took place. Hosted by the Canadian Institute for Health Information (CIHI) in collaboration with the Institute of Health Economics (IHE) and the Canadian Health Services Research Foundation…
26 – 27 October 2010 Edmonton, Alberta As part of the Alberta Ambassador Guideline Adaptation Program, on October 26 & 27, 2010, the Institute of Health Economics (IHE) conducted an invitational workshop on the optimal use of diagnostic imaging (CT and MRI) based on the recommendations from the low back pain guideline. Download Workshop Summary Encouraging Optimal Use…
14 October 2010 Edmonton, Alberta Emceed by Don Newman, national journalist and broadcaster and Chair of Canada 2020, this fifth session considered the following theme: Innovation and Sustainability in Health Systems. Speakers from all sectors provided a range of perspectives on how to foster innovation and drive towards a more sustainable healthcare system. Key Forum Documents…
23 – 24 September 2010 Edmonton, Alberta Advancements in methodological approaches in the evaluation of health technologies are important for ensuring ongoing improvement in the comprehensiveness and quality of assessments. On September 23 and 24th, 2010, The Institute of Health Economics (IHE) conducted an invitational methodology forum addressing the economic evaluation…
18 July 2010 Calgary, Alberta In order to better understand Mental Health & Addictions in the Workplace, the PNWER Health Care Working Group hosted a half day session in conjunction with the annual PNWER summit. This session brought together key policy experts, decision makers, clinicians, and business leaders, and provided the opportunity for dialogue around this issue. Mental…
22 April 2010 Edmonton, Alberta Emceed by Tom Feasby, the University of Calgary‘s Dean of Medicine, this fourth session considered the following theme: Innovation and Economics: Investing in the Future Health System. Speakers from all sectors provided a range of perspectives on the best ways to direct resources so as to ensure a real return on investment. Key Forum Documents…
8 – 9 April 2010 Edmonton, Alberta There is a wealth of theoretical and real-world evidence on the impacts of physician payment system design on physician behavior and health system performance. In order to bring some of that knowledge to Alberta the Institute of Health Economics (IHE) conducted, on behalf of Alberta Health and Wellness, a 1 and ½ day Provider Funding:…
5 February 2010 Edmonton, Alberta The Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like? program presented some of the latest international and Canadian developments in policy in this important area. It also included presentations from experts and interactive discussion amongst the participants. Download Workshop Summary Maximizing Patient…
23 – 25 April 2007 Calgary, Alberta The Institute of Health Economics (IHE) co-hosted this Calgary conference in April 2007 to consult experts on factors contributing to the low birth weight rate in Alberta, to develop a consensus on the relevant factors, and to tailor interventions to address the contributing factors. The consensus statement on how to prevent low birth weight…
A successful screening program for cystic fibrosis (CF) refers to the ability of the program to appropriately identify and refer for care those with CF, while meeting the needs of those who do not have CF, particularly those infants identified by the screening program as carriers (individuals unaffected by CF but have a mutation in one of their CFTR genes). Some measures of success…
The use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening. Permanent congenital hearing impairment/loss (PCHI) is one of the most common congenital anomalies found at birth which can be expected to lead to delays and deficits in the development of speech, language, cognition and learning, as well as secondary effects on the…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #21. The three objectives of this assessment are to determine the available scientific evidence on: the effective time interval for mammography screening in asymptomatic women aged 50 to 69 years; the effective screening interval in asymptomatic women between the ages of 40 and 49 years; and the mortality rate…